Literature DB >> 28799856

Severity of Airflow Obstruction in Chronic Obstructive Pulmonary Disease (COPD): Proposal for a New Classification.

Sonia Coton1, William M Vollmer2, Eric Bateman3, Guy B Marks4, Wan Tan5, Filip Mejza6, Sanjay Juvekar7, Christer Janson8, Kevin Mortimer9, Mahesh P A10, A Sonia Buist11, Peter G J Burney12.   

Abstract

Current classifications of Chronic Obstructive Pulmonary Disease (COPD) severity are complex and do not grade levels of obstruction. Obstruction is a simpler construct and independent of ethnicity. We constructed an index of obstruction severity based on the FEV1/FVC ratio, with cut-points dividing the Burden of Obstructive Lung Disease (BOLD) study population into four similarly sized strata to those created by the GOLD criteria that uses FEV1. We measured the agreement between classifications and the validity of the FEV1-based classification in identifying the level of obstruction as defined by the new groupings. We compared the strengths of association of each classification with quality of life (QoL), MRC dyspnoea score and the self-reported exacerbation rate. Agreement between classifications was only fair. FEV1-based criteria for moderate COPD identified only 79% of those with moderate obstruction and misclassified half of the participants with mild obstruction as having more severe COPD. Both scales were equally strongly associated with QoL, exertional dyspnoea and respiratory exacerbations. Severity assessed using the FEV1/FVC ratio is only in moderate agreement with the severity assessed using FEV1 but is equally strongly associated with other outcomes. Severity assessed using the FEV1/FVC ratio is likely to be independent of ethnicity.

Entities:  

Keywords:  Epidemiological studies; GOLD classification; method comparison; spirometry

Mesh:

Year:  2017        PMID: 28799856     DOI: 10.1080/15412555.2017.1339681

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  5 in total

1.  The Flow-Volume Loop: Always an Inspiration!

Authors:  Charles G Irvin
Journal:  COPD       Date:  2020-06-08       Impact factor: 2.069

2.  Profile: Vadu Health and Demographic Surveillance System Pune, India.

Authors:  Rutuja Patil; Sudipto Roy; Vijendra Ingole; Tathagata Bhattacharjee; Bharat Chaudhary; Pallavi Lele; Siddhivinayak Hirve; Sanjay Juvekar
Journal:  J Glob Health       Date:  2019-06       Impact factor: 4.413

3.  Airflow Obstruction and Cardio-metabolic Comorbidities.

Authors:  Filip J J Triest; Michael Studnicka; Frits M E Franssen; William M Vollmer; Bernd Lamprecht; Emiel F M Wouters; Peter G J Burney; Lowie E G W Vanfleteren
Journal:  COPD       Date:  2019-05-27       Impact factor: 2.409

4.  How to Stage Airflow Limitation in Stable Chronic Obstructive Pulmonary Disease Male Patients?

Authors:  Ichraf Anane; Fatma Guezguez; Hend Knaz; Helmi Ben Saad
Journal:  Am J Mens Health       Date:  2020 May-Jun

5.  COPD assessment test and FEV1: do they predict oxygen uptake in COPD?

Authors:  Luiz Carlos S Carvalho-Jr; Renata Trimer; Guilherme Pt Arêas; Flávia Cr Caruso; Katiany Tl Zangrando; Soraia Pilon Jürgensen; José C Bonjorno; Cláudio Ricardo de Oliveira; Ramona Cabiddu; Renata G Mendes; Audrey Borghi-Silva
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-10-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.